Summary
BTG plc (BTG) is a healthcare company that develops, manufactures and sells medicines for acute care, cancer and vascular diseases. The company develops specialty drugs including antidotes for snake envenomation and toxicity related to medicines used for heart conditions and cancer; interventional vascular products for treating patients with severe blood clots and varicose veins; and interventional cancer products for treating patients with liver tumors and emphysema. The company develops its own products and acquires or in-licenses them from others. BTG markets its products either directly or through distribution agreements. The company operates along with its subsidiaries in the US, the UK, Guernsey, Australia and Germany. BTG is headquartered in London, the UK.
BTG Plc (BTG) - Medical Equipment - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.
GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.
Scope
- Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the company's operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.
Reasons to Buy
Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.
Understand the company's business segments' expansion / divestiture strategy
- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.
Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.
Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.
Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.
Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.
Note*: Some sections may be missing if data is unavailable for the company.
'
Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 5
BTG Plc, Medical Equipment, Deals By Year, 2011 to YTD 2017 6
BTG Plc, Medical Equipment Deals By Type, 2011 to YTD 2017 7
BTG Plc, Medical Equipment, Deals By Region, 2011 to YTD 2017 8
BTG Plc, Medical Equipment, Deals By Market, 2011 to YTD 2017 9
BTG Plc, Medical Equipment, Deals Summary, 2011 to YTD 2017 10
BTG Plc, Medical Equipment, Deal Details 12
Asset Purchase 12
BTG Completes Acquisition Of Targeted Therapies Business Of Nordion For US$200 Million 12
PneumRx Acquires Patents And Domain Names From Broncus Technologies 13
Venture Financing 14
PneumRx Secures US$33 Million In Series C Venture Financing Round 14
Partnerships 15
BTG Enters into Licensing Agreement with IMBiotechnologies 15
BTG Enters into Co-Development Agreement with Mirada Medical 16
Philips Partners Biocompatibles To Advance Image Guided Transarterial Embolizations In Interventional Oncology 16
MedX Health Enters Into An Agreement With Biocompatibles International 17
Equity Offering 18
BTG to Raise USD235 Million in Private Placement of Shares 18
Asset Transactions 19
Eckert & Ziegler Bebig To Acquire Brachytherapy Business Of Biocompatibles For US$5 Million 19
MedX Health Acquires Siascopy Assets From BTG For US$0.3 Million 20
Acquisition 21
BTG Acquires Galil Medical for up to USD110 Million 21
BTG Acquires PneumRx 22
BTG Completes Acquisition Of Ekos, Developer Of Drug Delivery System, For US$220 Million 24
BTG International Acquires Biocompatibles 26
BTG Plc - Key Competitors 29
Key Employees 30
Locations And Subsidiaries 31
Head Office 31
Other Locations & Subsidiaries 31
Recent Developments 33
Financial Announcements 33
Nov 15, 2016: BTG: Interim results 33
May 17, 2016: BTG: Final Results 34
Apr 08, 2016: Edison Issues ADR Update on BTG 39
Corporate Communications 40
Jul 27, 2016: BTG Announces Appointment of Non-executive Director 40
Product News 41
03/10/2016: BTG International Canada Expands Operations To Directly Sell Interventional Oncology Product Bead Block Microsphere 41
03/10/2016: BTG International Canada Expands Operations To Directly Sell Interventional Oncology Product DC Bead 42
03/10/2016: BTG International Canada Expands Operations To Directly Sell Interventional Oncology Product DC Bead M1 43
01/26/2016: First Patients in South Korea Receive TheraSphere Radioembolisation Treatment 44
Other Significant Developments 45
Oct 06, 2016: BTG: close period update 45
Jul 14, 2016: BTG: Annual General Meeting 46
Apr 05, 2016: BTG: Close Period Update 47
Appendix 48
Methodology 48
About GlobalData 48
Contact Us 48
Disclaimer 48
List of Tables
BTG Plc, Medical Equipment, Key Facts, 2016 1
BTG Plc, Medical Equipment, Deals Summary, 2011 to YTD 2017 1
BTG Plc, Medical Equipment, Deals By Year, 2011 to YTD 2017 6
BTG Plc, Medical Equipment Deals By Type, 2011 to YTD 2017 7
BTG Plc, Medical Equipment, Deals By Region, 2011 to YTD 2017 8
BTG Plc, Deals By Market, 2011 to YTD 2017 9
BTG Plc, Medical Equipment, Deals Summary, 2011 to YTD 2017 10
BTG Completes Acquisition Of Targeted Therapies Business Of Nordion For US$200 Million 12
PneumRx Acquires Patents And Domain Names From Broncus Technologies 13
PneumRx Secures US$33 Million In Series C Venture Financing Round 14
BTG Enters into Licensing Agreement with IMBiotechnologies 15
BTG Enters into Co-Development Agreement with Mirada Medical 16
Philips Partners Biocompatibles To Advance Image Guided Transarterial Embolizations In Interventional Oncology 16
MedX Health Enters Into An Agreement With Biocompatibles International 17
BTG to Raise USD235 Million in Private Placement of Shares 18
Eckert & Ziegler Bebig To Acquire Brachytherapy Business Of Biocompatibles For US$5 Million 19
MedX Health Acquires Siascopy Assets From BTG For US$0.3 Million 20
BTG Acquires Galil Medical for up to USD110 Million 21
BTG Acquires PneumRx 22
BTG Completes Acquisition Of Ekos, Developer Of Drug Delivery System, For US$220 Million 24
BTG International Acquires Biocompatibles 26
BTG Plc, Key Competitors 29
BTG Plc, Key Employees 30
BTG Plc, Subsidiaries 31
List of Figures
BTG Plc, Medical Equipment, Deals by Type, 2011 to YTD 2017 1
BTG Plc, Medical Equipment, Deals By Year, 2011 to YTD 2017 1
BTG Plc, Medical Equipment, Deals By Region, 2011 to YTD 2017 1
BTG Plc, Medical Equipment, Deals By Market, 2011 to YTD 2017 1
BTG Plc, Medical Equipment, Deals By Year, 2011 to YTD 2017 6
BTG Plc, Medical Equipment, Deals by Type, 2011 to YTD 2017 7
BTG Plc, Medical Equipment, Deals By Region, 2011 to YTD 2017 8
BTG Plc, Medical Equipment, Deals by Market, 2011 to YTD 2017 9
